CITADEL ADVISORS LLC 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Nektar Therapeutics NKTR | CITADEL ADVISORS LLC | 5,635,132 3.000% | -4,094,620 (-42.08%) | Filing |
| 2023-07-03 4:02 pm Purchase | 2023-06-23 | 13G | Nektar Therapeutics NKTR | CITADEL ADVISORS LLC | 9,729,752 5.100% | 9,729,752 (New Position) | Filing |